GlassScriptPhysician profile
John R Landry
NPI 1710936158
$4,519.07
in general payments reported to CMS, 2019-2025
17 companies · $1,280 in 2025
The $1,280 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,370 · 2020: $22.64 · 2021: $1,200 · 2022: $98.03 · 2023: $222 · 2024: $326 · 2025: $1,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025 · Travel and Lodging: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.00 |
| Travel and Lodging | $803.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,346.46 | 2019-2025 | |
| Treace Medical Concepts, INC. | $1,172.84 | 2019-2025 | |
| Nevro Corp. | $244.84 | 2024 | Senza |
| Bioventus LLC | $141.78 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $132.40 | 2023-2025 | Cadence, Evos, Pico 7 |
| Amgen INC. | $71.70 | 2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $56.97 | 2023-2025 | Nuzyra |
| Pacira Pharmaceuticals Incorporated | $50.80 | 2019-2020 | |
| Abbott Laboratories | $48.45 | 2022-2025 | Proclaim |
| Ibsa Pharma INC. | $43.54 | 2023 | Tirosint, Licart |
| Stryker Corporation | $39.78 | 2022 | |
| Solventum Corporation | $39.63 | 2024-2025 | Activ.A.C. |
| Orthofix Medical, INC. | $34.39 | 2022-2023 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $33.52 | 2019 | |
| Horizon Therapeutics Plc | $33.10 | 2023 | Krystexxa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.06 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Landry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.